Atsuhiro Kanda Selected Research

Atsuhiro Kanda Research Topics

Disease

23	Diabetic Retinopathy (Retinopathy, Diabetic) 07/2020 - 01/2012
14	Inflammation (Inflammations) 01/2020 - 05/2004
10	Macular Degeneration (Age-Related Maculopathy) 01/2021 - 10/2007
9	Neoplasms (Cancer) 11/2017 - 01/2011
7	Choroidal Neovascularization 07/2020 - 01/2012
6	Hypoxia (Hypoxemia) 07/2021 - 11/2017
6	Uveitis 07/2020 - 11/2012
4	Fibrosis (Cirrhosis) 01/2021 - 01/2019
3	Glaucoma 07/2021 - 01/2020
3	Epiretinal Membrane (Epiretinal Membranes) 01/2017 - 06/2012
3	Pterygium 08/2016 - 01/2011
2	Open-Angle Glaucoma (Glaucoma, Open Angle) 07/2021 - 07/2020
2	Neovascular Glaucoma 07/2021 - 07/2020
2	Low Tension Glaucoma 01/2020 - 10/2016
2	Animal Disease Models 01/2019 - 01/2016
2	Macular Edema 11/2017 - 01/2017
2	Ocular Paraneoplastic Syndromes 04/2017 - 01/2014
2	Retinal Diseases 01/2017 - 01/2012
2	Lymphoma (Lymphomas) 12/2014 - 05/2014
2	Infections 05/2004 - 03/2004
1	Acute zonal occult outer retinopathy 10/2021
1	Melanoma (Melanoma, Malignant) 07/2021
1	Photophobia (Light Sensitivity) 01/2021
1	Retinal Degeneration 10/2020
1	Herpes Zoster 07/2020
1	Cataract (Cataracts) 07/2020
1	Edema (Dropsy) 01/2020
1	Uveomeningoencephalitic Syndrome (Vogt Koyanagi Harada Syndrome) 08/2019

Drug/Important Bio-Agent (IBA)

16	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2021 - 01/2012
15	Retinaldehyde (Retinal)IBA 10/2021 - 10/2009
7	Galectin 1 (LGALS1)IBA 01/2021 - 12/2015
7	ReninIBA 07/2020 - 01/2012
7	Proteins (Proteins, Gene)FDA Link 01/2020 - 01/2012
7	Prorenin ReceptorIBA 09/2019 - 11/2014
4	AntibodiesIBA 10/2021 - 01/2013
4	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 01/2020 - 12/2015
3	Vascular Endothelial Growth Factor CIBA 07/2021 - 02/2013
3	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 07/2021 - 01/2013
3	InterleukinsIBA 10/2019 - 03/2004
3	RecoverinIBA 04/2017 - 01/2014
3	Crystallins (Crystallin)IBA 01/2016 - 06/2012
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2021 - 05/2014
2	Rhodopsin (Visual Purple)IBA 10/2020 - 06/2007
2	EnzymesIBA 07/2020 - 01/2013
2	Acrolein (Aqualin)IBA 01/2020 - 01/2017
2	AldehydesIBA 01/2020 - 01/2017
2	Therapeutic UsesIBA 01/2020 - 09/2019
2	Amino Acid Transport System X-AG (Glutamate Transporter)IBA 01/2020 - 10/2016
2	Adrenal Cortex Hormones (Corticosteroids)IBA 08/2019 - 04/2017
2	Advanced Glycation End ProductsIBA 01/2019 - 11/2017
2	Serine (L-Serine)FDA Link 01/2016 - 01/2013
2	Protein Kinases (Protein Kinase)IBA 01/2016 - 01/2013
2	AntigensIBA 01/2015 - 01/2014
2	Cell Adhesion MoleculesIBA 01/2013 - 01/2012
2	Monocyte Chemoattractant ProteinsIBA 01/2013 - 01/2012
2	Apolipoproteins E (ApoE)IBA 12/2011 - 06/2011
2	Protein Isoforms (Isoforms)IBA 06/2011 - 06/2007
2	Interleukin-8 (Interleukin 8)IBA 05/2004 - 03/2004
1	Glucose (Dextrose)FDA LinkGeneric 07/2021
1	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 01/2021
1	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 01/2021
1	LigandsIBA 01/2021
1	Carrier Proteins (Binding Protein)IBA 01/2021
1	p38 Mitogen-Activated Protein KinasesIBA 01/2021
1	Prostaglandins FIBA 01/2021
1	Connexin 43 (Connexin43)IBA 07/2020
1	Angiotensin IIIBA 07/2020
1	Tissue Plasminogen Activator (Alteplase)FDA Link 07/2020
1	AngiotensinogenIBA 07/2020
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 07/2020
1	Neutralizing AntibodiesIBA 07/2020
1	Platelet-Derived Growth FactorIBA 07/2020
1	UbiquitinIBA 01/2020
1	Triamcinolone Acetonide (Azmacort)FDA LinkGeneric 01/2020
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2020
1	DNA (Deoxyribonucleic Acid)IBA 01/2020
1	Messenger RNA (mRNA)IBA 01/2020
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2020
1	astaxanthine (astaxanthin)IBA 01/2020
1	Polyamine OxidaseIBA 01/2020
1	N- (3,5- bis(trifluoromethyl)phenyl)- 5- chloro- 2- hydroxybenzamideIBA 01/2020
1	GlucocorticoidsIBA 01/2020
1	Proline (L-Proline)FDA Link 09/2019
1	Small Interfering RNA (siRNA)IBA 09/2019
1	RNA (Ribonucleic Acid)IBA 01/2019
1	LectinsIBA 01/2019
1	Retinal Pigments (Pigments, Visual)IBA 01/2019
1	N(epsilon)-hexanoyllysineIBA 03/2018
1	Bevacizumab (Avastin)FDA Link 03/2018
1	Amine Oxidase (Copper-Containing)IBA 12/2017
1	SpermineIBA 12/2017
1	Toll-Like Receptors (Toll-Like Receptor)IBA 11/2017
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 06/2017

Therapy/Procedure

7	Lasers (Laser) 07/2020 - 01/2012
3	Therapeutics 08/2019 - 01/2013
2	RNAi Therapeutics 09/2019 - 06/2017
2	Drug Therapy (Chemotherapy) 04/2017 - 01/2014
1	Trabeculectomy (Trabeculoplasty) 07/2021
1	Intravitreal Injections 07/2020
1	Molecular Targeted Therapy 01/2019